Combining Flow Cytometry, IHC, and NGS in Immuno-oncology: The Essential Trio for Biomarker Assessment Success
Published: November 5, 2025
Dive into how combining flow cytometry, IHC, and NGS delivers a powerful, integrated approach for biomarker assessment in immuno-oncology. This post explains why no single technique is enough — and how the trio provides a fuller picture of the immune response, helping to stratify patients, monitor efficacy, and predict outcomes more reliably.
Reach out to our experts and discover how we can help you transform your research and advance health
